["{\n\"step_by_step_thinking\": \"The question is asking if αCGRP (alpha-CGRP) has amyloidogenic properties. To answer this, we need to look at the relevant documents. The first document talks about the pharmacological characterization of CGRP1 receptor subtype in the vascular system of the rat. It does not mention anything about amyloidogenic properties of αCGRP. The second document is about the presence of liver CGRP/amylin receptors in only nonparenchymal cells and absence of direct regulation of rat liver glucose metabolism by CGRP/amylin. Again, it does not mention anything about amyloidogenic properties of αCGRP. The third document is about human serum amyloid P-component (SAP) selectively binding to immobilized or bound forms of C-reactive protein (CRP). It does not mention αCGRP at all. The fourth document is about a new purification procedure for bovine C-reactive protein and serum amyloid P component. It also does not mention αCGRP. The fifth document is about a protease-sensitive site in the proposed Ca(2+)-binding region of human serum amyloid P component and other pentraxins. It talks about the cleavage of SAP by alpha-chymotrypsin, but it does not mention αCGRP.\n\nTherefore, based on the information provided, we cannot conclude that αCGRP has amyloidogenic properties or not.\",\n\"answer_choice\": B"]